1. Hurvitz Brain Sciences Program, Sunnybrook Research Institute and Departments of Psychiatry and Pharmacology; University of Toronto; Toronto Canada
2. Otsuka Pharmaceutical Development & Commercialization, Inc.; Princeton NJ USA
3. Department of Psychiatry; University of California; San Diego CA USA
4. Department of Medicine; University of California; San Diego CA USA
5. Interdisciplinary Brain Center, Massachusetts General Hospital and Harvard Medical School; Charlestown MA USA
6. Institute of Psychiatry, Psychology and Neuroscience, King's College London; London UK
7. University of Exeter; Exeter UK
8. Department of Health Promotion; School of Public Health, Sackler Faculty of Medicine and Minerva Center for the Interdisciplinary Study of End of Life, Tel Aviv University; Tel Aviv Israel
9. Department of Psychiatry; Hotchkiss Brain Institute, University of Calgary; Calgary Alberta Canada
10. Department of Psychiatry and Behavioral Sciences; Johns Hopkins Medicine Institutes; Baltimore MD USA
11. Bracket Global; Wayne PA USA
12. Department of Neurology; Hope Center for Neurological Disorders, and Knight Alzheimer Disease Research Center, Washington University School of Medicine; St. Louis MO USA
13. Center for Brain Health, NYU Langone Medical Center; New York NY USA
14. Department of Psychiatry and Behavioral Sciences; Johns Hopkins University School of Medicine; Baltimore MD USA
15. Eisai, Inc.; Woodcliff Lake NJ USA
16. Department of Psychiatry; University of Connecticut School of Medicine; Farmington CT USA
17. Banner Alzheimer's Institute; Phoenix AZ USA
18. Elverson PA USA
19. Alzheimer's Association; Chicago IL USA
20. Department of Neurology; Brigham and Women's Hospital, Harvard University School of Medicine; Boston MA USA
21. Voyager Therapeutics; Cambridge MA USA